---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-082433"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2026-07-10T12:06:31+00:00"
generated_at: "2026-07-10T12:10:10.527440+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# VYNE declares special cash dividend of $0.38/share in connection with Yarrow merger

## Summary
- Estimated aggregate $16.5M special cash dividend ($0.38/share) declared; record date July 22, 2026.
- Dividend conditioned on closing of merger with Yarrow Bioscience; expected close on/about July 24, 2026.
- Stockholder vote on merger scheduled for July 16, 2026; dividend payable after close.
- Per-share amount based on 42,989,506 shares and equivalents outstanding as of July 9, 2026.
- Actual distribution may be higher or lower than estimate; payment to transfer agent on July 23, 2026.

## SEC filing metadata
- accession: 0001104659-26-082433
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2026-07-10T12:06:31+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/0001104659-26-082433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/tm2620182d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-082433
- JSON: https://secwatch.observer/filing/0001104659-26-082433.json
- Plain text: https://secwatch.observer/filing/0001104659-26-082433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.